Bluejay Diagnostics Q1 EPS $(0.10) Down From $(0.06) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share. This is a 66.67 percent decrease over losses of $(0.06) per share from the same period last year.
Lannett And 4 Other Penny Stocks Bought By Insiders
US stock futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 18 companies made new 52-week lows.
Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package For The Symphony IL-6 Test Is With The FDA
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and
65 Biggest Movers From Yesterday
Gainers
Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.